Abstract:BackgroundRenal fibrosis is the common pathological feature of chronic kidney disease (CKD) that finally leads to end‐stage renal disease (ESRD) and renal failure. Resveratrol (RSV) has been widely used as nutrition supplement for metabolic diseases and anti‐cancer therapy, but its potential risk on kidney health has not been fully evaluated. In this study, we investigated the comprehensive effect of RSV on renal fibrosis in human tubular epithelial cells (TECs) line HK‐2.MethodsThe epithelial‐mesenchymal transition (EMT) in HK‐2 cells was induced by TGF‐β, and EMT cells were treated with a series concentration of RSV. The alteration of cell phenotype and EMT markers including E‐cadherin (E‐cad), ɑ‐smooth muscle actin (ɑ‐SMA) and fibronectin (FN) were analyzed. In addition, the effects of RSV on cell viability, LDH release, oxidative stress, mitochondrial function and cytoskeleton remodeling in HK‐2 cells were also measured.ResultsTGF‐β induced obvious pro‐fibrotic phenotype (reduced E‐cad, increased ɑ‐SMA and FN expression) and down‐regulated Sirt1 in HK‐2 cells, while low doses RSV (5–20 μM) suppressed the TGF‐β induced EMT via Sirt1‐dependent deacetylation of Smad3/4 mechanism. However, long‐term (72 hrs) of higher doses RSV (≥ 40 μM) treatment lost its anti‐fibrotic role in EMT cells despite sustained activation of Sirt1. In addition, higher doses RSV directly inhibited cell viability, induced oxidative stress and LDH release in HK‐2 cells. Further results revealed that higher doses RSV not only induced mitochondria dysfunction (elevated fragments and mtROS, reduced levels of ATP and mitochondrial biogenesis proteins), but also caused abnormal F‐actin redistribution and Rock1 signals activation.ConclusionThis study highlighted that RSV activated dose‐response anti‐fibrotic and pro‐fibrotic effect in TECs, and the adverse effect of RSV was respected to mitochondrial oxidative stress and Rock1‐mediated disordered cytoskeleton remodeling. Therefore, RSV dose should be carefully considered when used in patients with impaired kidney function.Support or Funding InformationThis work was supported by grants from National Natural Science Foundation of China (31200754, 81571808).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Resveratrol Suppresses the Myofibroblastic Phenotype and Fibrosis Formation in Kidneys Via Proliferation‐related Signalling Pathways

Resveratrol Inhibits Epithelial-Mesenchymal Transition and Renal Fibrosis by Antagonizing the Hedgehog Signaling Pathway

MiR-155-5p Promotes Renal Interstitial Fibrosis in Obstructive Nephropathy Via Inhibiting SIRT1 Signaling Pathway

Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction

Resveratrol Exerts Dose‐response Anti‐fibrotic and Pro‐fibrotic Effect in Renal Tubular Epithelial Cells

Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosis

Resveratrol Exerts Dose-Dependent Anti-Fibrotic or Pro-Fibrotic Effects in Kidneys: A Potential Risk to Individuals with Impaired Kidney Function

ResveratroI attenuates renaI interstitiaI fibrosis by inhibiting activationof sonic hedgehog signaIing in rats with uniIateraI ureteraI obstruction

Quercetin Inhibits the Amphiregulin/egfr Signaling‐mediated Renal Tubular Epithelial‐mesenchymal Transition and Renal Fibrosis in Obstructive Nephropathy

MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1

renal interstitial fi brosis in obstructive nephropathy by interfering TGF-b 1 / Smad 3 signaling †

Inhibition of STAT3 Acetylation is Associated with Attenuated Renal Fibrosis in the Obstructed Kidney

Resveratrol Alleviates Hepatic Fibrosis in Associated with Decreased Endoplasmic Reticulum Stress-Mediated Apoptosis and Inflammation

Inhibiting Aerobic Glycolysis Suppresses Renal Interstitial Fibroblast Activation and Renal Fibrosis.

SKLB023 Hinders Renal Interstitial Fibrosis in Obstructive Nephropathy by Interfering TGF-β1/Smad3 Signaling

Metformin Prevents Renal Fibrosis In Mice With Unilateral Ureteral Obstruction And Inhibits Ang Ii-Induced Ecm Production In Renal Fibroblasts

Resveratrol Inhibits High Glucose Induced Collagen Upregulation in Cardiac Fibroblasts Through Regulating TGF-β1-Smad3 Signaling Pathway.

Resveratrol inhibits the expression of typeⅠ and type Ⅲ collagen induced by AngⅡ in cardiac fibroblasts through regulating the TGF-β1/Smad3 signaling pathway

Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF‐κB and the PI3K/Akt Signaling Pathway

MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells

Endothelial Dysfunction Exacerbates Renal Interstitial Fibrosis Through Enhancing Fibroblast Smad3 Linker Phosphorylation In The Mouse Obstructed Kidney